WHITNEY BLACK: Open Payments
NPI 1881373488 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$803 in 32 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $803
Food & beverage: $803
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 9 | $296 |
| Braeburn Inc. | 8 | $178 |
| Otsuka America Pharmaceutical, Inc. | 4 | $97 |
| Indivior Inc. | 3 | $84 |
| ABBVIE INC. | 4 | $67 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $42 |
| ViiV Healthcare Company | 1 | $24 |
| Lundbeck LLC | 1 | $16 |
Products named: BRIXADI, Yeztugo, REXULTI, SUBLOCADE, CAPLYTA, VRAYLAR, MAVYRET, APRETUDE.
Industry payments across KY — which companies pay providers there.
